Ethionamide pharmacokinetics in multidrugresistant tuberculosis patients with and without HIVinfection

Loading...
Thumbnail Image

Date

2017

Journal Title

Journal ISSN

Volume Title

Publisher

University of the Western Cape

Abstract

Many studies have investigated the pharmacokinetics (PK) of anti-tuberculosis drugs in tuberculosis patients. However, currently in South Africa, no studies have been done on ethionamide (ETH) PK in adult MDR-TB patients that are infected with HIV and those without HIV infection. Therefore, the objective of this current study was firstly, to find out ethionamide plasma concentration using the LC-MS method; secondly, to evaluate and compare the pharmacokinetics of ethionamide in MDR-TB patients infected with and without HIV infection; thirdly, to examine the effects of ARVs and kidney impairment on the PK of ethionamide and fourthly, to find out the consequence of sex and age on ETH PK parameters.

Description

Magister Pharmaceuticae - Mpharm

Keywords

Multidrug-resistant tuberculosis, Human immunodeficiency virus, Mycobacterium tuberculosis, Antiretroviral agents, Ethionamide, Pharmacokinetics, Plasma concentrations, Liquid chromatography, Mass spectrometry

Citation